Mediation Analyses Link Cardiometabolic Factors and Liver Fat With White Matter Hyperintensities and Cognitive Performance: A UK Biobank Study

中介分析揭示心血管代谢因素和肝脏脂肪与白质高信号及认知功能之间的联系:一项英国生物银行研究

阅读:1

Abstract

BACKGROUND: Liver fat is associated with cardiometabolic disease, cerebrovascular disease, and dementia. Cerebrovascular disease, most often cerebral small vessel disease, identified by magnetic resonance imaging as white matter hyperintensities (WMHs) often contributes to dementia. However, liver fat's role in the relationship between cardiometabolic risk, WMHs, and cognitive performance is unclear. METHODS: In the UK Biobank cohort (N = 32,461, 52.6% female; mean age 64.2 ± 7.7 years; n = 23,354 in the cognitive performance subsample), we used linear regression to investigate associations between cardiometabolic factors measured at baseline and liver fat, WMHs, and cognitive performance measured at follow-up, which was 9.3 ± 2.0 years later on average. We used structural equation modeling to investigate whether liver fat mediated associations between cardiometabolic factors and WMHs and whether WMHs mediated associations between liver fat and cognitive performance. RESULTS: Nearly all cardiometabolic factors were significantly associated with liver fat (|r| range = 0.03-0.41, p = 3.4 × 10(-8) to 0) and WMHs (|r| = 0.04-0.15, p = 5.8 × 10(-13) to 7.0 × 10(-159)) in regression models. Liver fat was associated with WMHs (r = 0.11, p = 4.3 × 10(-82)) and cognitive performance (r = -0.03, p = 1.6 × 10(-7)). Liver fat mediated the associations between cardiometabolic factors and WMHs (|β(mediation)| = 0.003-0.027, p (mediation) = 1.9 × 10(-8) to 0), and WMHs mediated the associations between liver fat and cognitive performance (β(mediation) = -0.01, p (mediation) = 0). CONCLUSIONS: Our findings indicate that liver fat mediates associations between cardiometabolic factors and WMHs and that WMHs mediate the association between liver fat and cognitive performance. This suggests that liver fat may be important for understanding the effects of cardiometabolic factors on cerebrovascular disease and cognitive function. Experimental studies are warranted to determine relevant targets for preventing vascular-driven cognitive impairment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。